Although various molecular markers involved in chemotherapy resistance have been investigated, their direct roles in the chemosensitivity and prognostic value of gliomas, except MGMT (O6-methylguanine DNA methyltransferase), remain controversial [20]. This evidence concerns the gene MGMT and glioma.